Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017;69:692–711. https://doi.org/10.1016/j.jacc.2016.11.042.

Article  CAS  PubMed  Google Scholar 

Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18:e308–19. https://doi.org/10.1016/j.jacl.2024.03.001.

Article  PubMed  Google Scholar 

Schmidt K, Noureen A, Kronenberg F, Utermann G. Structure, function, and genetics of lipoprotein (a). J Lipid Res. 2016;57:1339–59. https://doi.org/10.1194/jlr.R067314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang AY, Han SH, Sohn IS, Oh PC, Koh KK. Lipoprotein(a) and Cardiovascular Diseases - Revisited. Circ J. 2020;84:867–74. https://doi.org/10.1253/circj.CJ-20-0051.

Article  CAS  PubMed  Google Scholar 

Bhatia HS, Wilkinson MJ. Lipoprotein(a): Evidence for role as a causal risk factor in cardiovascular disease and emerging therapies. J Clin Med. 2022;11:6040. https://doi.org/10.3390/jcm11206040.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saeed A, Kinoush S, Virani SS. Lipoprotein (a): Recent Updates on a Unique Lipoprotein. Curr Atheroscler Rep. 2021;23:41. https://doi.org/10.1007/s11883-021-00940-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nordestgaard BG, Nicholls SJ, Langsted A, Ray KK, Tybjaerg-Hansen A. Advances in lipid-lowering therapy through gene-silencing technologies. Nat Rev Cardiol. 2018;15:261–72. https://doi.org/10.1038/nrcardio.2018.3.

Article  CAS  PubMed  Google Scholar 

Chapman MJ, Orsoni A, Robillard P, Therond P, Giral P. Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. J Clin Lipidol. 2018;12(784–800):e784. https://doi.org/10.1016/j.jacl.2018.02.001.

Article  Google Scholar 

Bittner VA, Schwartz GG, Bhatt DL, Chua T, De Silva HA, Diaz R, et al. Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study. J Clin Lipidol. 2024;18:e548–61. https://doi.org/10.1016/j.jacl.2024.04.122.

Article  PubMed  Google Scholar 

Enkhmaa B, Berglund L. Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis. 2022;349:53–62. https://doi.org/10.1016/j.atherosclerosis.2022.04.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B. Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol. 1995;15:847–9. https://doi.org/10.1161/01.atv.15.7.847.

Article  CAS  PubMed  Google Scholar 

Frohlich J, Dobiasova M, Adler L, Francis M. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Physiol Res. 2004;53:481–6.

Article  CAS  PubMed  Google Scholar 

Malek F, Dvorak J, Skalnikova V, Mates M, Kmonicek P, Vavrova Z, et al. Correlation of lipoprotein(a) with the extent of coronary artery disease in patients with established coronary atherosclerosis: gender differences. Eur J Prev Cardiol. 2015;22:603–5. https://doi.org/10.1177/2047487314527849.

Article  PubMed  Google Scholar 

Forbang NI, Criqui MH, Allison MA, Ix JH, Steffen BT, Cushman M, et al. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2016;63:453–8. https://doi.org/10.1016/j.jvs.2015.08.114.

Article  PubMed  Google Scholar 

Allard MD, Saeedi R, Yousefi M, Frohlich J. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort. Lipids Health Dis. 2014;13:65. https://doi.org/10.1186/1476-511X-13-65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johansen AK, Bogsrud MP, Christensen JJ, Rundblad A, Narverud I, Ulven S, et al. Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up. Atheroscler Plus. 2023;51:28–34. https://doi.org/10.1016/j.athplu.2023.01.001.

Article  PubMed  PubMed Central  Google Scholar 

Markus MRP, Ittermann T, Schipf S, Bahls M, Nauck M, Volzke H, et al. Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20:168. https://doi.org/10.1186/s12933-021-01363-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010;56:1252–60. https://doi.org/10.1373/clinchem.2010.146779.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marlega-Linert J, Wartecka-Zielinska K, Wydra D, Fijalkowski M, Gruchala M, Mickiewicz A. Case report: lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia. Front Med (Lausanne). 2023;10:1190446. https://doi.org/10.3389/fmed.2023.1190446.

Article  PubMed  Google Scholar 

Manten GT, Voorbij HA, Hameeteman TM, Visser GH, Franx A. Lipoprotein (a) in pregnancy: a critical review of the literature. Eur J Obstet Gynecol Reprod Biol. 2005;122:13–21. https://doi.org/10.1016/j.ejogrb.2005.03.013.

Article  CAS  PubMed  Google Scholar 

Simony SB, Mortensen MB, Langsted A, Afzal S, Kamstrup PR, Nordestgaard BG. Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study. Atherosclerosis. 2022;355:76–82. https://doi.org/10.1016/j.atherosclerosis.2022.06.1023.

Article  CAS  PubMed  Google Scholar 

Anagnostis P, Karras S, Lambrinoudaki I, Stevenson JC, Goulis DG. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. Int J Clin Pract. 2016;70:967–77. https://doi.org/10.1111/ijcp.12903.

Article  CAS  PubMed  Google Scholar 

Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. J Am Heart Assoc. 2023;12: e031255. https://doi.org/10.1161/JAHA.123.031255.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia. J Am Heart Assoc. 2019;8: e013225. https://doi.org/10.1161/JAHA.119.013225.

Article  PubMed  PubMed Central  Google Scholar 

Langsted A, Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4:577–87. https://doi.org/10.1016/S2213-8587(16)30042-0.

Article  CAS  PubMed  Google Scholar 

Haines CJ, Cheung LP, Lam CW. Changes in atherogenic lipids and lipoproteins during natural and hyperstimulated cycles in healthy women. Fertil Steril. 1997;68:231–5. https://doi.org/10.1016/s0015-0282(97)81507-5.

Article  CAS  PubMed  Google Scholar 

Ricci G, Tamaro G, Simeone R, Giolo E, Nucera G, De Seta F, et al. Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH. Hum Reprod. 2001;16:449–56. https://doi.org/10.1093/humrep/16.3.449.

Article  CAS  PubMed